REG - Medica Group PLC - Director/PDMR Shareholding
05/07/2023 15:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230705:nRSE0950Fa&default-theme=true
RNS Number : 0950F Medica Group PLC 05 July 2023
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 4 July 2023, the PDMRs
listed below had options that vested and were exercised due to the approval of
Scheme of Arrangement via Court Sanction hearing. The exercised options were
ordinary shares of 0.2p each in the Company under the Company's Performance
Share Plan 2017, Deferred Bonus Plan 2017 and Save As You Earn Scheme:
Name of PDMR Number of shares subject to options
Stuart Quin 744,671
Richard Jones 545,399
Kevin Terrins 284,292
Sarah Burns 226,457
Marc O'Brien 288,130
Caroline Byrne 139,141
Rob Lavis 193,342
Fiona Carr 43,780
Kim Scanlan 32,905
The notifications set out below are provided in accordance with the
requirements of the UK Market Abuse Regulation, and set out more details of
the transactions.
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
2. Reason for notification
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Company's
Performance Share Plan 2017
(c) Price(s) and volume £Nil Option Price in each case
1. 597,579
2. 454,832
3. 217,565
4. 175,869
5. 212,516
6. 85,323
7. 154,811
8. 37,141
9. 32,905
(d) Aggregated information N/A
(e) Date of the transaction 4 July 2023
(f) Place of the transaction Outside a trading venue
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
2. Reason for notification
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Deferred Bonus
Plan 2017
(c) Price(s) and volume £Nil Option Price in each case
1. 129,092
2. 82,006
3. 48,727
4. 42,027
5. 57,614
6. 53,818
7. 35,107
8. 5,725
9. -
(d) Aggregated information N/A
(e) Date of the transaction 4 July 2023
(f) Place of the transaction Outside a trading venue
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
2. Reason for notification
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Save As Your Earn
Scheme 2020
(c) Price(s) and volume £1.00 Option Price in each case
1. 18,000
2. -
3. 18,000
4. -
5. 18,000
6. -
7. -
8. -
9. -
(d) Aggregated information N/A
(e) Date of the transaction 4 July 2023
(f) Place of the transaction Outside a trading venue
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
2. Reason for notification
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Save As Your Earn
Scheme 2021
(c) Price(s) and volume £1.46 Option Price in each case
1. -
2. 8,561
3. -
4. 8,561
5. -
6. -
7. 3,424
8. -
9. -
(d) Aggregated information N/A
(e) Date of the transaction 4 July 2023
(f) Place of the transaction Outside a trading venue
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
2. Reason for notification
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Save As Your Earn
Scheme 2022
(c) Price(s) and volume £1.422 Option Price in each case
1. -
2. -
3. -
4. -
5. -
6. -
7. -
8. 914
9. -
(d) Aggregated information N/A
(e) Date of the transaction 4 July 2023
(f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHNKPBNQBKDPOKRecent news on Medica
See all newsREG - Stock Exch Notice Medica Group PLC - Cancellation - Medica Group plc
AnnouncementREG - Medica Group PLC - De-listing and Cancellation of Trading of Shares
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Medica Group plc
AnnouncementREG - Credit Industriel Medica Group PLC - Form 8.3 - Medica Group plc
Announcement